These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16260054)

  • 1. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
    Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
    Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
    Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
    Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.
    Mohanti BK; Umapathy H; Bahadur S; Thakar A; Pathy S
    Radiother Oncol; 2004 Jun; 71(3):275-80. PubMed ID: 15172142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
    Chen AM; Vaughan A; Narayan S; Vijayakumar S
    Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated, palliative radiotherapy for advanced head and neck cancer.
    Agarwal JP; Nemade B; Murthy V; Ghosh-Laskar S; Budrukkar A; Gupta T; D'Cruz A; Pai P; Chaturvedi P; Dinshaw K
    Radiother Oncol; 2008 Oct; 89(1):51-6. PubMed ID: 18649963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
    Kil WJ; Camphausen K
    Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
    Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
    Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
    Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
    Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of postoperative radiotherapy in patients with pathologic N1 neck disease.
    Jäckel MC; Ambrosch P; Christiansen H; Martin A; Steiner W
    Head Neck; 2008 Jul; 30(7):875-82. PubMed ID: 18302275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.